These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. Fan NJ; Gao CF; Wang CS; Zhao G; Lv JJ; Wang XL; Chu GH; Yin J; Li DH; Chen X; Yuan XT; Meng NL J Proteomics; 2012 Jul; 75(13):3977-86. PubMed ID: 22583932 [TBL] [Abstract][Full Text] [Related]
3. Biomarker Discovery and Verification of Esophageal Squamous Cell Carcinoma Using Integration of SWATH/MRM. Hou G; Lou X; Sun Y; Xu S; Zi J; Wang Q; Zhou B; Han B; Wu L; Zhao X; Lin L; Liu S J Proteome Res; 2015 Sep; 14(9):3793-803. PubMed ID: 26224564 [TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus. Zhou G; Li H; Gong Y; Zhao Y; Cheng J; Lee P; Zhao Y Proteomics; 2005 Sep; 5(14):3814-21. PubMed ID: 16127732 [TBL] [Abstract][Full Text] [Related]
8. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111 [TBL] [Abstract][Full Text] [Related]
9. Comparative proteomic analysis of esophageal squamous cell carcinoma. Qi Y; Chiu JF; Wang L; Kwong DL; He QY Proteomics; 2005 Jul; 5(11):2960-71. PubMed ID: 15986332 [TBL] [Abstract][Full Text] [Related]
10. Proteogenomic examination of esophageal squamous cell carcinoma (ESCC): new lines of inquiry. Dagamajalu S; Vijayakumar M; Shetty R; Rex DAB; Narayana Kotimoole C; Prasad TSK Expert Rev Proteomics; 2020 Sep; 17(9):649-662. PubMed ID: 33151123 [No Abstract] [Full Text] [Related]
11. Discovery and validation of combined biomarkers for the diagnosis of esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma. Zheng YQ; Huang HH; Chen SX; Xu XE; Li ZM; Li YH; Chen SZ; Luo WX; Guo Y; Liu W; Li EM; Xu LY J Proteomics; 2024 Jul; 304():105233. PubMed ID: 38925350 [TBL] [Abstract][Full Text] [Related]
12. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma. Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660 [TBL] [Abstract][Full Text] [Related]
13. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method. Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038 [TBL] [Abstract][Full Text] [Related]
14. [Differential proteins in esophageal squamous cell line EC9706/CDDP identified by SILAC quantitative proteomic approach]. Wang P; Gao XF; Bu WY; Zhang J; Hou YF; Niu BH; Wang W; Ma YF; Qi YJ Yao Xue Xue Bao; 2012 Mar; 47(3):409-16. PubMed ID: 22645768 [TBL] [Abstract][Full Text] [Related]
15. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions. Wang M; Smith JS; Wei WQ Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970 [TBL] [Abstract][Full Text] [Related]
16. iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma. Deng F; Zhou K; Li Q; Liu D; Li M; Wang H; Zhang W; Ma Y Tumour Biol; 2016 Feb; 37(2):1909-18. PubMed ID: 26330293 [TBL] [Abstract][Full Text] [Related]